Prevention Valuation: Fund Health, Not Just Sav...

By Rene Pretorius

May 9, 2025

Prevention promises healthier lives, but how should we value it? Prevention valuation is critical for funding in value-based care systems. The proverb "
Wegovy CVS Deal: Hybrid Market Access Strategy Insights
Journavx for Pain Management: Toward Affordability and Access
Reassuring the Private Sector on National Health Insurance South Africa: A Pa...
A Shared-Value Model for Enhancing Diabetes Care in South Africa
Prior Authorization Elimination: Is Optum Rx moving towards Access Efficiency?
Systems Thinking in Pharmaceutical Access: Future-Proofing Value Strategy
Journavx Market Access Strategy in Focus: What Early Payer Decisions Signal f...
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
CMS Price Negotiations: Bridging the Gap in US Drug Pricing
Access to Anti-Obesity Medication for Medicare and Medicaid
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...
Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA